Diabete Metab
The medications are also being studied in late stages of clinical development for chronic kidney disease and non-alcoholic fatty liver disease, where theyve shown promise
Tirzepatide, a GLP-1 receptor agonist, regulates appetite and glucose levels, making it an effective tool for weight management and improving insulin sensitivity
Dual-Core Cell Regeneration (GHK-Cu + EGF) Experience the synergistic power of Blue Copper Peptide and EGF (Epidermal Growth Factor)
You may have a higher risk of eye-related side effects if you have: Existing eye conditions, especially diabetic retinopathy Diabetes-related eye disease High blood pressure High cholesterol Sleep apnea These conditions may also have an impact on vision, which makes it difficult to fully understand the impact of GLP-1 medications, says Dr
Ageeva, T., Rizvanov, A., & Mukhamedshina, Y